baber/WOPTO huggingface dataset:
Patent CA-2800733-A1 (CA)
Inventor: FRUCHEY OLAN S
IPC: C12P7/44
Filed: 2011-06-10
Abstract: Processes for making hydrogenated products including caprolactame (CL) caprolactone (CLO) or 1,6-hexanediol (HDO) and derivative thereof from monoammonium adipate (MAA) and/or adipic acid (AA) obtained from a clarified diammonium adipate-containing (DAA-containing) fermentation broth or monoammonium adipate-containing (MAA-containing) fermentation broth.
Patent CA-2801163-A1 (CA)
Inventor: ANDERSSON JAN-ERIK
IPC: B25J9/10
Filed: 2011-06-01
Abstract: A milking arrangement comprises a milking robot (10). The robot comprises a first link L1), a second link (L2), a third link (L3), an end effector (E), sensor (16) and a control unit (15). The first link is rotatable to a first angle within a first angle range (a1) via a first joint (11). The second link is rotatable to a second angle within a second angle range (a2) via a second joint (12). The third link (L3) is rotatable to a third angle within a third angle range (a3) via third joint (13), The links (L1, L2, L3) are rotatable so that the end effector is movable within a three-dimensional workspace (W). Each position of the end effector within the workspace corresponds to a single combination of the first, second and third angles.
Patent CA-2802330-A1 (CA)
Inventor: NEUMANN KARL-ERIK
IPC: B25J17/02
Filed: 2011-06-09
Abstract: A parallel-kinematical machine (20) that includes three setting devices (24.1, 24.2, 24.3) each of which can be lengthened and shortened individually, wherein each setting device (24.1, 24.2, 24.3) is connected to a first, a second and a third respective inner gimbal ring (23.1, 23.2, 23.3) of universal gimbal joints (UGJ) and that each inner gimbal ring (23.1, 23.2, 23.3) is mounted in bearings (25, 26, 27) for rotation in gimbal holders (21, 22) which are rotationally mounted in outer gimbal bearings (28, 29, 39) in an outer mounting (290) wherein the first inner gimbal ring (23.1) and the third inner gimbal ring (23.3) are mounted for rotation in a common outer gimbal holder (21) which is mounted for rotation about a common gimbal axis (32, 52) and in that the second inner gimbal ring (23.2) is mounted for rotation in a single gimbal holder (22) which is mounted in two opposite bearings for rotation about a second gimbal axis (31, 51) which is not aligned with said common gimbal axis (32, 52).
Patent CA-2805688-A1 (CA)
Inventor: THORE PIERRE
IPC: G01V1/30
Filed: 2011-07-19
Abstract: In accordance with the 4D seismic technique, a base seismic trace is measured at a first time in a region of the subsoil, and then a monitor seismic trace corresponding to the base seismic trace is measured at a second time. To interpret the 4D measurements, assumptions are made about the variation of elastic parameters in permeable layers at predefined positions in one direction between the first and the second time. Elastic parameters include the density (?) and the speed of propagation of the pressure waves (V P) in the permeable layers. Numerical evaluation is performed for a capability of each assumption about the variation of elastic parameters to give an account of a change between the measured base seismic trace and the measured monitor seismic trace, and the variation of the elastic parameters is estimated in accordance with an assumption of optimum capability.
Patent CA-2805899-A1 (CA)
Inventor: BINNER CURT
IPC: A61C17/02
Filed: 2011-07-22
Abstract: L'invention porte sur des dispositifs de prélèvement d'un échantillon de fluide provenant de la cavité buccale, le dispositif comprenant un embout buccal qui comprend une chambre, celle-ci comprenant des parois internes avant et arrière, sur des moyens de prélèvement de l'échantillon de fluide provenant de la cavité buccale, ainsi que sur des procédés de prélèvement et d'analyse d'échantillons de fluide provenant de la cavité buccale qui comprennent les étapes suivantes : le positionnement du dispositif dans la cavité buccale, le prélèvement de l'échantillon de fluide et la conduite d'une analyse de l'échantillon de fluide.
Patent CA-2807234-A1 (CA)
Title: Container cap and seal assemblies
Inventor: PEREZ DANIEL
IPC: B65D41/30
Filed: 2011-08-04
Abstract: A container, cap and seal assembly (10) comprises a container base (20), a cap (30) and a seal (40) engagable with the container base. The seal is held on the cap when the cap is initially installed on the base. When the cap is subsequently opened, the seal disengages from the cap and remains on the base. The seal may then be manually removed and re- installed on the base as desired. The container, cap and seal assembly may be used to contain pastes, liquids and other flowable materials.
Patent CA-2807496-A1 (CA)
Title: 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
Inventor: CHO AESOP
IPC: A61K31/41
Filed: 2011-03-22
Abstract: Provided are select imidazo[1,2-f][1,2,4] triazinyl nucleosides, nucleoside phosphates and prodrugs thereof, wherein the 2' position of the nucleoside sugar is substituted with halogen and carbon substituents. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections caused by both wild type and mutant strains of HCV. Formula (I)
Patent CA-2807502-A1 (CA)
Title: Adiabatic compressed air energy storage process
Inventor: KIDD H ALLAN
IPC: F02C7/00
Filed: 2011-07-26
Abstract: A compressed air energy storage system including a compressor adapted to receive a process gas and output a compressed process gas. A heat transfer unit may be coupled to the compressor and adapted to receive the compressed process gas and a heat transfer medium and to output a cooled process gas and a heated heat transfer medium. A compressed gas storage unit may be coupled to the heat transfer unit and adapted to receive and store the cooled process gas. A waste heat recovery unit may be coupled to the heat transfer unit and adapted to receive the heated heat transfer medium.
Patent CA-2813812-A1 (CA)
Inventor: MASCARENHAS ANGELO
IPC: H01L31/0288
Filed: 2011-03-08
Abstract: Isoelectronic co-doping of semiconductor compounds and alloys with acceptors and deep donors is used to decrease bandgap, to increase concentration of the dopant constituents in the resulting alloys, and to increase carrier mobilities lifetimes. For example, Group III-V compounds and alloys, such as GaAs and GaP, are isoelectronically co-doped with, for example, B and Bi, to customize solar cells, and other semiconductor devices. Isoelectronically co-doped Group II-VI compounds and alloys are also included.
Patent CA-2817527-A1 (CA)
Inventor: DEPESTELE MARC
IPC: B32B5/28
Filed: 2011-06-30
Abstract: The subject of the present invention is a flexible preform for producing, by heating and shaping, a component based on natural fibres, said preform being characterized in that it consists of a core made of a nonwoven of natural fibres, at least one surface of which is bonded to a woven fabric made of natural fibres.
Patent CA-2818299-A1 (CA)
Inventor: DE VRIES LOUWE
IPC: C07K7/14
Filed: 2011-11-22
Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
Patent CA-2818548-A1 (CA)
Title: Neutralizing anti-ccl20 antibodies
Inventor: IMAI TOSHIO
IPC: C07K16/46
Filed: 2011-11-18
Abstract: The disclosure provides humanized, chimeric and murine antibodies that specificity bind to the human CC chemokine ligand 20 (CCL20). The disclosure further provides heavy chains and light chains of the antibodies, as well as isolated nucleic acids, recombinant vectors and host cells that comprise a sequence encoding a heavy chain and/or light chain of the antibodies. Further disclosed are methods of using the anti-CCL20 antibodies for treating disorders including inflammatory and autoimmune disorders as well as cancers.
Patent CA-2819009-A1 (CA)
Title: Substituted benzopyrazin derivatives as fgfr kinase inhibitors for the treatment of cancer diseases
Inventor: BERDINI VALERIO
IPC: C07D403/04
Filed: 2011-11-29
Abstract: The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Patent CA-2819337-A1 (CA)
Title: Food ingredient comprising hydrolyzed whole grain
Inventor: SCHAFFER-LEQUART CHRISTELLE
IPC: A23L7/10
Filed: 2010-12-08
Abstract: The present invention relates to a food ingredient comprising a savoury flavour component, a hydrolyzed whole grain composition and an alpha-amylase or fragment thereof, which alpha-amylase or fragment thereof shows no hydrolytic activity towards dietary fibers when in the active state.
Patent CA-2820910-A1 (CA)
Inventor: NASR-EL-DIN HISHAM
IPC: C09K8/60
Filed: 2011-12-14
Abstract: The present invention relates to a process for treating a sandstone formation comprising introducing a fluid containing glutamic acid ?,?-diacetic acid or a salt thereof (GLDA) and having a pH of between 1 and 14 into the formation. The invention in addition relates to a fluid and a kit of parts suitable for use in the above process containing glutamic acid ?,?-diacetic acid or a salt thereof (GLDA), a corrosion inhibitor, a surfactant, and optionally a mutual solvent.
Patent CA-2821490-A1 (CA)
Inventor: LEE YINGYEN
IPC: E05B67/22
Filed: 2013-07-22
Abstract: A non-numeric, non-textual, color-coded combination locking device has a body, a locking mechanism, and a plurality of dial wheels with colors indicia as identifying members. The wheels rotate relative to the body and locking mechanism and display a plurality of colors across the device. The wheels and the color indicia are configured to simultaneously display colors across the device. The design provides users a different way to remember the unlocking codes in colors instead of numbers and/or letters.
Patent CA-2823067-A1 (CA)
Inventor: ROHLMANN MICHAEL
IPC: F16L9/128
Filed: 2012-02-04
Abstract: The invention relates to a composite material comprising reinforcing fibres and a matrix of matrix material surrounding said reinforcing fibres. The matrix material contains a resin and the reinforcing fibres contain polyphenylene sulfide.
Patent CA-2823077-A1 (CA)
Inventor: HORTNAGL ANDREAS
IPC: A44B11/10
Filed: 2011-12-27
Abstract: The invention relates to a buckle (1) for fixing at least one band (2), said buckle (1) having at least one buckle main part (3) and at least one clamping web (5) which is mounted on the buckle main part (3) in a movable manner in at least one moving direction (4) in order to clamp the band (2) that is ran around the clamping web (5). The clamping web (5) has at least one clamping web main part (6) that is mounted on the buckle main part (3) in a movable manner and a clamping limb (7) that projects beyond the clamping web main part (6) in order to contact the band (2) that is ran around the clamping web (5).
Patent CA-2823419-A1 (CA)
Title: Building stucture systems
Inventor: SCHIFFMANN GLENN P
IPC: E04B2/00
Filed: 2011-10-11
Abstract: Light weight fiber-reinforced polymeric (FRP) structural building panels and panel assemblies, sized and configured for construction of wall structures permanently tied to the ground, optionally tying overlying structure to an underlying footer through such panels and panel assemblies. Footers are fabricated by flowing fluid concrete under segments of the wall while anchors extend down from the wall into the space into which concrete is being flowed. Fiber schedule and orientation in the panels provide enhanced properties of strength of a panel/wall per unit dimension relative to FRP layer thickness and/or mass of the panel/wall per unit dimension. Panel profiles as molded, and molds to make such profiles, enhance panel fabrication.
Patent CA-2824864-A1 (CA)
Inventor: LI WEI
IPC: C07D519/00
Filed: 2012-02-15
Abstract: The invention relates to benzodiazepine derivatives with antiproliferative activity and more specifically to benzodiazepine compounds of formula (I)-(VII) and as exemplified generally by formula (I): (see formula I) The invention also provides conjugates of the benzodiazepine compounds linked to a cell-binding agent. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention.
Patent CA-2826592-A1 (CA)
Inventor: THOREEN ADAM MARSHALL
IPC: G01C23/00
Filed: 2012-04-17
Abstract: A system for displaying pitch- and power-based guidance commands and flight path information for a variety of display modes (climb, cruise, descent, landing) to pilots in response to situations wherein the measured air data should not be relied upon. This information is presented in an intuitive and expedient manner exactly when and where it is needed on the primary flight display. The displayed information dynamically changes in response to airplane parameters.
Patent CA-2827496-A1 (CA)
Inventor: KERN PETER
IPC: G01N33/53
Filed: 2013-09-16
Abstract: The invention is based on a device (10a-e; 10g-j; 101-w) for performing a biochemical analysis, especially in outer space, more particularly an immunoassay, in which analysis at least one analyte in a sample (44a; 44n-o; 44r; 44u; 44v) is determined selectively, having at least one reaction container (12a-j; 12n-w, 14a; 14p-t, 16p-t, 18p-t) which has at least one work volume (20a-j; 20n-w, 22a; 22n; 22p-v, 24p-t, 26p-t) which is intended for taking in a liquid volume and for performing at least one substep of an analysis reaction, and having at least one interface (60a-j; 60n-v, 62a-j; 62n-t; 62v, 64a; 64d; 64n-q; 64s-t; 64v, 66a; 66o-q; 66s-t, 68o-q; 68s-t, 70s) which is intended for connecting at least one work volume (20a-j; 20n-w, 22a; 22n; 22p-v, 24p-t, 26p-t) to a further media container (28a; 28k-l; 28n-t; 28v-w, 30a; 30n-q; 30s-t; 30w, 32o-q; 32s-t, 34o-q; 34s-t, 36o-q; 36s-t, 38a; 38n-o; 38r; 38u-v). It is proposed that the reaction container (12a-j; 12n-w, 14a; 14p-t, 16p-t, 18p-t) be implemented as a container which is at least substantially completely closed in the assembled state.
Patent CA-2830451-A1 (CA)
Inventor: CLARKE ALASTAIR ROBERT
IPC: A61F9/00
Filed: 2012-04-11
Abstract: An apparatus for intraocular injection comprising a body (101) adapted to accommodate an injection device, a displacement device (110) coupled to a distal end (102) of the body (101), and a sleeve (104) coupled to the body (101) and axially moveable relative to the body (101). The displacement device (110) includes at least one rotatable member adapted to contact a superficial layer of an eye (50), and the sleeve (104) engages and causes rotation of the at least one rotatable member as the sleeve moves from a first axial position to a second axial position. Rotation of the at least one rotatable member displaces the superficial layer relative to an underlying layer of the eye (50).
Patent CA-2834101-A1 (CA)
Inventor: KITADE MAKOTO
IPC: A61K31/4439
Filed: 2012-01-06
Abstract: The purpose of the present invention is to provide a novel indazole compound which is capable of inhibiting HSP90 and has a cytostatic effect. Another purpose of the present invention is to provide a drug useful for preventing and/or treating, on the basis of an HSP90 inhibitory effect, a disease in which HSP90 participates, in particular, cancer. A compound represented by general formula (I) or a salt thereof [in formula (I), X, Y1 to Y4, A, B and R1 to R8 are each as defined in claims of the present application].
Patent CA-2834238-A1 (CA)
Title: Compositions comprising a glucose anti-metabolite and selenium
Inventor: LUHADIYA ASHOK PREMCHAND
IPC: A23K10/33
Filed: 2012-05-02
Abstract: A composition including a glucose anti-metabolite and selenium. The composition can be for a companion animal. The composition can include added selenium and endogenous selenium. The composition can be a nutritionally balanced pet food composition.
Patent CA-2834668-A1 (CA)
Title: Method and system for purifying pyrolysis oil
Inventor: MENSE MARTIN
IPC: C10G31/10
Filed: 2012-05-18
Abstract: The invention relates to a method for purifying pyrolysis oil, comprising at least the following steps: a) at least purifying the pyrolysis oil in a centrifuge; and b) before and/or during the purification according to step a), heating the pyrolysis oil in order to reduce the viscosity of the pyrolysis oil. The invention further relates to a system for purifying pyrolysis oil.
Patent CA-2840112-A1 (CA)
Inventor: HEINRICH TIMO
IPC: A61P35/00
Filed: 2012-05-29
Abstract: Compounds of the formula (I) in which R1, R2 and R3 are each as defined in Claim 1 are inhibitors of PDK1 and of cell proliferation/cell vitality and can be used for treatment of tumours.
Patent CA-2842059-A1 (CA)
Inventor: CARUEL PIERRE
IPC: F02K1/72
Filed: 2012-07-05
Abstract: L'invention concerne une nacelle (1) pour turboréacteur comprenant une partie fixe (5) et des moyens d'inversion de poussée (15) comprenant: -un capot d'inverseur dont la partie aval forme une tuyère d'éjection; -des grilles de déviation; -des volets d'inversion de poussée; -des moyens d'actionnement. Sous l'effet des moyens d'actionnement, les moyens d'inversion de poussée (15) se translatent entre une position d'escamotage du capot d'inverseur correspondant à un fonctionnement de la nacelle (1) en jet direct, et une position déployée du capot d'inverseur correspondant à un fonctionnement de la nacelle (1) en jet inverse. La nacelle(1)est remarquable en ce que l'étirement desdits moyens d'actionnement a pour seul effet d'entraîner une variation de la section de tuyère tant que ledit étirement est inférieur à une valeur prédéterminée, et de découvrir les grilles et de déployer les volets après dépassement de ladite valeur prédéterminée.
Patent CA-2843327-A1 (CA)
Inventor: EICHSTAEDT MATTHIAS
IPC: G06Q30/02
Filed: 2012-07-25
Abstract: In an embodiment, a method comprises causing, to be displayed to a user through a web page of a social network provider that provides a social network, contest data that indicates an online contest; receiving, at a particular entity, input that indicates an intention by the user to participate in the online contest; sending, from the particular entity, request data that indicates a request, by the particular entity, for one or more permissions that allows the particular entity to access information from the social network provider about the user; after sending the request data, receiving, at the particular entity, acceptance data that indicates that the user accepts the request; in response to receiving the acceptance data, causing the user to be entered in the online contest; wherein the method is performed by one or more computing devices.
Patent CA-2843676-A1 (CA)
Title: Fuel cell and fuel cell stack exhibiting connectivity over long term usage
Inventor: HOTTA NOBUYUKI
IPC: H01M8/02
Filed: 2012-08-07
Abstract: Provided is a fuel cell including a pair of interconnectors (IC's); a cell main body provided between the ICs, and which includes an electrolyte, a cathode formed on one surface of the electrolyte, and an anode formed on the other surface of the electrolyte; and a current collection member provided between the cathode and the anode, and the IC  which electrically connects the cathode or the anode, and the IC. The fuel cell current collection member has a connector abutment portion which abuts the IC, a cell main body abutment portion which abuts the cell main body, and a connection portion which connects the connector abutment portion and the cell main body abutment portion, the portions being continuously formed; and, between the cell main body and the IC, a spacer is provided so as to separate the connector abutment portion and the cell main body abutment portion from each other.
Patent CA-2846069-A1 (CA)
Inventor: RAJAGOPAL VIDYA
IPC: H04W84/20
Filed: 2014-03-13
Abstract: An electronic control unit (ECU) is tested by an automated D-bus testing tool in a first device. The test tool establishes one or more secure shells between the first device and the ECU. The tool reads test input data from an Excel input file. The ECU comprises a software stack including a test client, a Bluetooth middle layer and a hardware abstraction layer, that communicate internally relative to the ECU, via a D-bus. The test tool sends function calls and parameters via the secure shells to the ECU to test execution of Bluetooth functions and/or Bluetooth profiles. The function calls enable simulation of a human machine interface by the test client. The tool monitors API call returns and logs D-bus communications via the one or more secure shells. The test tool outputs test verdict information and/or D-bus communication logs as text in an Excel file.
Patent CA-2847855-A1 (CA)
Title: Secure key self-generation
Inventor: BERENBERG PAUL
IPC: G06F21/00
Filed: 2012-09-14
Abstract: Techniques are disclosed for providing secure critical security parameter (CSP) generation in an integrated circuit (IC). Embodiments generally include determining that an ability to read the CSP externally (e.g., through a debug interface) has been disabled before the CSP is generated. Depending on the functionality of the device, embodiments can include other steps, such as determining whether software for executing a method for providing a secure CSP is being run for a first time. Among other things, the techniques provided herein for providing secure CSP generation can increase the security of the CSP and reduce manufacturing costs of the IC.
Patent CA-2849298-A1 (CA)
Inventor: KRIZMAN DAVID B
IPC: G01N33/53
Filed: 2012-09-24
Abstract: Specific peptides, and derived ionization characteristics of those peptides from Death Receptor 5 (DR5) protein are provided that are particularly advantageous for quantifying the DR5 protein directly in biological samples that have been fixed in formalin by the method of Selected Reaction Monitoring / Multiple Reaction Monitoring (SRM/MRM) mass spectrometry. Such biological samples are chemically preserved and fixed wherein the biological sample is selected from tissues and cells treated with formaldehyde containing agents/fixatives including formalin-fixed tissue/cells, formalin-fixed/paraffin embedded (FFPE) tissue/cells, FFPE tissue blocks and cells from those blocks, and tissue culture cells that have been formalin fixed and or paraffin embedded. A protein sample is prepared from a biological sample using the Liquid Tissue reagents and protocol, and the DR5 protein are quantitated in the Liquid Tissue sample by the method of SRM/MRM mass spectrometry by quantitating in the protein sample at least one or more of the peptides described for one or more of the DR5 protein. These peptides can be quantitated if they reside in a modified or in an unmodified form. An example of a modified form of a DR5 peptide is phosphorylation of a tyrosine, threonine, serine, and/or other amino acid residues within the peptide sequence
Patent CA-2849885-A1 (CA)
Inventor: IYER PRASHANT
IPC: C12P19/14
Filed: 2012-09-21
Abstract: The present invention relates enzyme composition comprising a cellulolytic preparation and an acetylxylan esterase (AXE); and the used of cellulolytic enzyme compositions for hydrolyzing acetylated cellulosic material. Finally the invention also relates to processes of producing fermentation products from acetylated cellulosic materials using a cellulolytic enzyme composition of the invention.